Alpha 2.0
Login Register
» Articles » PMID: 4919352

Concentration of Homovanillic Acid in the Ventricular Fluid of Patients with Parkinson's Disease and Other Dyskinesias

Overview
Journal Neurology
Specialty Neurology
Date 1970 Oct 1
PMID 4919352
Citations 5
Authors
R PAPESCHI
T L Sourkes
J Hardy
C Bertrand
Affiliations
Soon will be listed here.
Citing Articles

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Agundez J Front Cell Neurosci. 2014; 8:369.

PMID: 25426023 PMC: 4227512. DOI: 10.3389/fncel.2014.00369.

Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Mann J, Stanley M, Kaplan R, Sweeney J, Neophytides A J Neurol Neurosurg Psychiatry. 1983; 46(10):905-10.

PMID: 6644314 PMC: 1027603. DOI: 10.1136/jnnp.46.10.905.

[Modern treatment of parkinsonism].

Birkmayer W, Neumayer E Z Neurol. 1972; 202(4):257-80.

PMID: 4117647

Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.

Spissu A, Corsini G, Marrosu F, Mangoni A Psychopharmacologia. 1975; 44(3):311-2.

PMID: 1208766 DOI: 10.1007/BF00428914.

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Campanella G, Algeri S, Cerletti C, Dolfini E, JORI A, Rinaldi F Eur J Clin Pharmacol. 1977; 11(4):255-61.

PMID: 862646 DOI: 10.1007/BF00607673.